{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:44:14Z","timestamp":1792813454513,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970772"],"award-info":[{"award-number":["81970772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20488"],"award-info":[{"award-number":["U23A20488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32201157"],"award-info":[{"award-number":["32201157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371033"],"award-info":[{"award-number":["82371033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171386"],"award-info":[{"award-number":["32171386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["21JCZDJC01250"],"award-info":[{"award-number":["21JCZDJC01250"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023\\u202FM730002"],"award-info":[{"award-number":["2023\\u202FM730002"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jconrel.2024.11.046","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:26:22Z","timestamp":1732677982000},"page":"399-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Subconjunctival injection of microcrystalline prodrug of dexamethasone for long-acting anti-inflammation after phacoemulsification surgery"],"prefix":"10.1016","volume":"377","author":[{"given":"Xueyan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunkai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanliang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.11.046_bb0005","doi-asserted-by":"crossref","first-page":"15014","DOI":"10.1038\/nrdp.2015.14","article-title":"Cataract","volume":"1","author":"Lam","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICU.0000000000000340","article-title":"The global state of cataract blindness","volume":"28","author":"Lee","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0015","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s12325-020-01383-1","article-title":"Persistence of inflammation after uncomplicated cataract surgery: a 6-month laser flare photometry analysis","volume":"37","author":"De Maria","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0161-6420(99)00082-2","article-title":"Inflammation after sclerocorneal versus clear corneal tunnel phacoemulsification","volume":"107","author":"Dick","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ICU.0000000000000912","article-title":"Management of inflammation after the cataract surgery","volume":"34","author":"Grzybowski","year":"2023","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/encyclopedia3030065","article-title":"Improving compliance with medical treatment using eye drop aids","volume":"3","author":"Biran","year":"2023","journal-title":"Encyclopedia"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.survophthal.2020.01.002","article-title":"Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management","volume":"65","author":"Roberti","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2021.06.017","article-title":"Challenges and opportunities in the development of complex generic long-acting injectable drug products","volume":"336","author":"O'Brien","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306463","article-title":"Long-acting ocular injectables: are we looking in the right direction?","volume":"11","author":"Dang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0065","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/S0161-6420(01)00839-9","article-title":"Randomized clinical trial of surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two surodex in the eye","volume":"108","author":"Tan","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122625","article-title":"Reverse engineering the ozurdex dexamethasone intravitreal implant","volume":"634","author":"Costello","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2019.06.006","article-title":"Hybrid drug nanocrystals","volume":"143","author":"Lu","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.powtec.2020.07.091","article-title":"Impact of nanoparticle size and solid state on dissolution rate by investigating modified drug powders","volume":"376","author":"Liu","year":"2020","journal-title":"Powder Technol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121515","article-title":"Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: bioavailability comparison","volume":"615","author":"Naageshwaran","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0095","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40265-020-01344-6","article-title":"Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation","volume":"80","author":"Lee","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0100","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jcrs.2018.07.015","article-title":"Safety of IBI-10090 for inflammation associated with cataract surgery: phase 3 multicenter study","volume":"44","author":"Donnenfeld","year":"2018","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ophtha.2024.03.025","article-title":"Triamcinolone acetonide subconjunctival injection as stand-alone inflammation prophylaxis after phacoemulsification cataract surgery","volume":"131","author":"Shorstein","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0110","first-page":"774","article-title":"Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery","volume":"12","author":"Jagadeesh Kumar","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41563-020-0674-z","article-title":"A year-long extended release nanoformulated cabotegravir prodrug","volume":"19","author":"Kulkarni","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114860","article-title":"Prodrug approaches for the development of a long-acting drug delivery systems","volume":"198","author":"Chien","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0130","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s40265-016-0645-5","article-title":"Paliperidone palmitate intramuscular 3-monthly formulation: a review in schizophrenia","volume":"76","author":"Lamb","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0135","article-title":"Advances in acid-degradable and enzyme-cleavable linkers for drug delivery","author":"Zhao","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0140","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1021\/acs.molpharmaceut.2c00348","article-title":"Microcrystals of ketal-linked paliperidone prodrugs for long-acting antipsychotics","volume":"19","author":"Xu","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0145","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1021\/acs.nanolett.9b05340","article-title":"Modular acid-activatable acetone-based ketal-linked nanomedicine by dexamethasone prodrugs for enhanced anti-rheumatoid arthritis with low side effects","volume":"20","author":"Xu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0150","first-page":"213","article-title":"Intra-articular injection of acid-sensitive stearoxyl-ketal-dexamethasone microcrystals for long-acting arthritis therapy, Asian","volume":"16","author":"Xu","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0155","doi-asserted-by":"crossref","DOI":"10.1063\/5.0118311","article-title":"Long-acting acid-sensitive ketal-linked dexamethasone microcrystals for treating experimental autoimmune uveitis","volume":"6","author":"Cai","year":"2022","journal-title":"APL Bioeng."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0160","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jcrs.2017.08.010","article-title":"Clinical implication of triamcinolone in aqueous humor after depository sub-tenon application","volume":"43","author":"Xu","year":"2017","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0170","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41467-021-25856-1","article-title":"Modular ketal-linked prodrugs and biomaterials enabled by organocatalytic transisopropenylation of alcohols","volume":"12","author":"Yu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/pharmaceutics11120651","article-title":"Dry tablet formulation of plga nanoparticles with a preocular applicator for topical drug delivery to the eye","volume":"11","author":"Ryu","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/pharmaceutics10040249","article-title":"Investigation of combined cyclodextrin and hydrogel formulation for ocular delivery of dexamethasone acetate by means of experimental designs","volume":"10","author":"Mazet","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0185","doi-asserted-by":"crossref","first-page":"1218297","DOI":"10.1155\/2018\/1218297","article-title":"Unravelling the interplay between extracellular acidosis and immune cells","volume":"2018","author":"Erra D\u00edaz","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2019.01.015","article-title":"Dexamethasone palmitate nanoparticles: an efficient treatment for rheumatoid arthritis","volume":"296","author":"Lorscheider","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120509","article-title":"Tiny dexamethasone palmitate nanoparticles for intravitreal injection: optimization and in vivo evaluation","volume":"600","author":"Canioni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2020.11.053","article-title":"In vivo fate of liposomes after subconjunctival ocular delivery","volume":"329","author":"Chaw","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf4608","article-title":"Six-month effective treatment of corneal graft rejection","volume":"9","author":"Meng","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.01.009","article-title":"Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats","volume":"201","author":"Pan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0215","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1039\/C7TB01556A","article-title":"Sustained subconjunctival delivery of cyclosporine a using thermogelling polymers for glaucoma filtration surgery","volume":"5","author":"Sun","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0220","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/s41598-018-24545-2","article-title":"Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0225","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jconrel.2020.08.019","article-title":"Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats","volume":"327","author":"Yang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjophthalmol-2017-310324","article-title":"Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and delphi survey","volume":"101","author":"Aptel","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0235","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of tnf-\u03b1 in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0240","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.17-21421","article-title":"Iris damage is associated with elevated cytokine levels in aqueous humor","volume":"58","author":"Aketa","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2016.09.003","article-title":"Steroid-induced ocular hypertension\/glaucoma: focus on pharmacogenomics and implications for precision medicine","volume":"56","author":"Fini","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0250","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jcrs.2018.09.022","article-title":"Changes in aqueous oxidative stress, prostaglandins, and cytokines: comparisons of low-energy femtosecond laser-assisted cataract surgery versus conventional phacoemulsification","volume":"45","author":"Liu","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0255","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1167\/iovs.15-16744","article-title":"Aqueous humor outflow: dynamics and disease","volume":"56","author":"Roy Chowdhury","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0260","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2021.12.011","article-title":"Effect of particle size on in vivo performances of long-acting injectable drug suspension","volume":"341","author":"Ho","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.122.001477","article-title":"Pharmacokinetic\/pharmacodynamic modeling of dexamethasone anti-inflammatory and immunomodulatory effects in LPS-challenged rats: a model for cytokine release syndrome","volume":"384","author":"\u015awierczek","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.03.041","article-title":"The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension","volume":"230","author":"Darville","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.molimm.2015.07.034","article-title":"Glucose, glycolysis and lymphocyte responses","volume":"68","author":"Donnelly","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","article-title":"Metabolic signatures of t-cells and macrophages in rheumatoid arthritis","volume":"46","author":"Weyand","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/eji.201646477","article-title":"Lactate at the crossroads of metabolism, inflammation, and autoimmunity","volume":"47","author":"Pucino","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0295","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/jps.24014","article-title":"Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats","volume":"103","author":"Darville","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.11.046_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12049","article-title":"Analgesic nanomedicines for the treatment of chronic pain","volume":"2","author":"Liu","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.jconrel.2024.11.046_bb0305","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jtos.2022.08.005","article-title":"Understanding chronic ocular surface pain: an unmet need for targeted drug therapy","volume":"26","author":"Galor","year":"2022","journal-title":"Ocul. Surf."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924008010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924008010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:46:28Z","timestamp":1777509988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924008010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":61,"alternative-id":["S0168365924008010"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.046","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subconjunctival injection of microcrystalline prodrug of dexamethasone for long-acting anti-inflammation after phacoemulsification surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}